India, Bangladesh, Thailand, Singapore, Turkey, Malaysia Explore New Healthcare Markets as Medical Tourism Declines : Why You Need to Know About It NOW!

Sunday, March 2, 2025

India’s medical value tourism (MVT) sector, once a thriving industry attracting international patients seeking affordable and high-quality healthcare, has been significantly impacted by a decline in patient arrivals from Bangladesh. Recent data from the Ministry of Tourism has revealed a sharp drop in medical travelers, with a 43% year-on-year (YoY) decline in November 2024 and an even steeper 59% decline in December 2024.

Industry experts have linked this downturn to a deterioration in bilateral relations between India and Bangladesh, along with increased visa restrictions that have made it difficult for Bangladeshi patients to seek treatment in Indian hospitals. This decline has been particularly concerning for medical institutions in Kolkata and the northeastern states, which rely heavily on international patients, primarily from Bangladesh.

The Economic and Tourism Impact of Medical Tourism Decline

Hospitals and healthcare providers in India, especially in the eastern and northeastern regions, have already started feeling the economic impact of reduced medical tourism. The sharp decline in Bangladeshi patients has not only affected healthcare facilities but also impacted the hospitality and travel sectors, which cater to international medical tourists and their families.

Among the major hospital chains, analysts have predicted that Apollo Hospitals (APHS) may face the greatest impact, whereas Aster DM Healthcare (ASTERDM) and Fortis Healthcare (FORH) may experience a comparatively lesser decline. These predictions align with a broader market trend where hospitals with a diverse patient base are better positioned to withstand the ongoing crisis.

Bangladesh accounts for nearly 70% of India’s medical tourism arrivals, making it the most significant source market. The total number of foreign tourist arrivals (FTA) from Bangladesh fell by 44% in November 2024 and 67% in December 2024, with only 60,800 visitors recorded in December—a stark 70% drop from the peak in June 2024.

Challenges in Visa Processing and Transportation Barriers

Industry analysts have pointed out that India’s scaled-down visa operations for Bangladesh and limited availability of transport services have made medical travel increasingly difficult. While the resumption of freight train services between India and Bangladesh after a nine-month suspension has been viewed as a positive development, experts believe that a full recovery in medical value tourism will take longer.

Visa constraints have further complicated the situation, as many patients currently seeking treatment in India had applied for visas before the crisis escalated, but new applications remain heavily restricted. This has left hospitals struggling to compensate for the sudden reduction in international patients.

The Need for Diversification in Medical Tourism Markets

The decline in Bangladeshi medical travelers has reignited discussions about the need for India to expand its medical tourism outreach beyond a single dominant market. A recent policy brief by the Indian Council for Research on International Economic Relations (ICRIER) titled Looking Beyond Bangladesh: Making India’s Medical Value Travel Sector More Resilient has emphasized the importance of diversifying India’s MVT base to ensure long-term sustainability.

Key takeaways from the ICRIER report suggest that:

• In 2022, Bangladesh accounted for 69% of India’s medical tourists. This over-reliance has made India vulnerable to sudden disruptions in bilateral relations.
• Other countries, like Thailand and Malaysia, have successfully diversified their medical tourism base. Thailand, for instance, attracts patients from China, the Middle East, and Europe, while Malaysia and Singapore actively promote their healthcare services to Indonesia, Australia, and Gulf nations.
• India, despite offering medical treatments at 65% lower costs than Western countries, remains heavily dependent on a narrow set of international patients.

India’s Medical Tourism Standing in the Global Market

Despite its reputation as a global medical tourism hub, India ranked 10th in the Global Medical Tourism Index (2020-21), falling behind countries like Thailand, Singapore, and Turkey. Experts believe that while India has world-class hospitals and competitive pricing, visa restrictions, lack of awareness about hospital accreditation, and limitations in international insurance acceptance have hindered its growth.

The ICRIER report also highlighted structural challenges that continue to limit India’s ability to attract a diverse range of medical travelers:

• Accreditation Issues: While India has over 1,200 hospitals accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), many international patients prefer hospitals accredited by the Joint Commission International (JCI)—a standard recognized more widely in Western and Middle Eastern countries.
• Lack of Insurance Portability: International patients from regions such as Iraq, Yemen, and Nigeria often struggle with medical insurance portability, requiring them to bear treatment costs out-of-pocket.
• Unregulated Medical Facilitators: The presence of unregulated agents in medical tourism has caused concerns about transparency, pricing, and credibility.
• Concentration of Medical Tourism in Metro Cities: Most internationally accredited hospitals are concentrated in Delhi, Mumbai, Chennai, and Bengaluru, limiting accessibility for patients from smaller regions.

Solutions to Strengthen India’s Medical Tourism Sector

To counter the effects of the decline in Bangladeshi medical travelers, the ICRIER report has recommended a series of strategic changes to make India’s medical tourism industry more resilient and competitive. These include:

• Expanding Medical Outreach to Africa, the Middle East, and Developed Markets: Encouraging patients from regions like the UAE, Nigeria, Kenya, and Australia could help India build a more diverse international patient base.
• Enhancing Awareness of NABH Accreditation: More global outreach efforts are needed to promote India’s nationally accredited hospitals as centers of medical excellence.
• Streamlining the Visa Process: The introduction of e-medical visas for a wider range of countries would make it easier for patients to travel for treatment.
• Regulating Medical Facilitators: Establishing a transparent system for medical facilitators could help improve credibility and pricing transparency.
• Strengthening Digital Payment and Insurance Infrastructure: Expanding digital payment options and facilitating insurance portability for international patients could encourage more people to choose India for medical treatment.

Global Impact: What This Means for Travelers

The decline in medical tourism from Bangladesh is not just an economic issue for India—it also reflects the global challenges in cross-border healthcare access. Countries that over-rely on specific source markets risk economic disruptions when diplomatic tensions, visa restrictions, or logistical barriers arise.

For international travelers seeking medical care, these changes highlight the importance of:

• Diversified medical tourism options: Patients may begin exploring alternative destinations such as Thailand, Singapore, and Turkey for their treatments.
• Greater focus on international accreditation: More emphasis may be placed on hospitals with globally recognized standards like JCI accreditation.
• Increased reliance on digital healthcare solutions: Telemedicine and cross-border medical insurance services could play a more significant role in facilitating international healthcare access.

Looking Ahead: The Future of India’s Medical Tourism Industry

As India grapples with the decline in Bangladeshi medical tourists, the long-term outlook suggests a need for structural reforms. A more diversified approach to international patient outreach, coupled with policy improvements in visa regulations and healthcare accreditation, will be crucial in maintaining India’s status as a competitive global healthcare destination.

While India’s affordability and quality of care remain unmatched, its ability to adapt to changing global dynamics will determine its success in the evolving medical tourism landscape.